Could a gentler hormone strategy be just as effective for advanced thyroid cancer?
NCT ID NCT06790589
First seen Feb 06, 2026 · Last updated May 22, 2026 · Updated 12 times
Summary
This study compares two ways of using thyroid hormone medication to suppress TSH in people with advanced thyroid cancer that has spread or returned. The standard approach keeps TSH very low (below 0.1), but this can cause side effects. The study will test if a slightly higher TSH target (0.1 to 0.5) works just as well to keep cancer from growing. About 70 adults in Alberta will take part, and researchers will track cancer progression and symptom burden over one year.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED DIFFERENTIATED THYROID GLAND CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.